Company: SUPN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001104659-25-042531
Chunk: 17

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 17
---
 copy of the Code of Ethics is currently available at ir.supernus.com/corporate-governance. Supernus will publicly disclose any waivers or amendments to the Code of Ethics that apply to the Chief Executive Officer (CEO) and senior financial officers pursuant to the requirements of the SEC. Composition of Our Board of Directors Our Board of Directors currently consists of six members. Our Class I directors were elected by our stockholders at the 2022 Annual Meeting of Stockholders, our Class II directors were elected by our stockholders at the 2023 Annual Meeting of Stockholders, and our Class III directors were elected by our stockholders at the 2024 Annual Meeting of Stockholders. Our Governance and Nominating Committee and Board of Directors may consider a broad range of factors relating to the qualifications and background of nominees. Our Governance and Nominating Committee’s and Board of Directors’ priority in selecting Board members is identification of persons who will further the interests of our stockholders through their established records of professional accomplishment, the ability to contribute positively to the collaborative culture among Board members, and professional and personal experiences and expertise relevant to our growth strategy. The Nasdaq Stock Market does not require us to disclose demographic information about the members of our Board of Directors. On an aggregate basis, the Board of Directors considers 67% of its members to be diverse, taking into account gender, race, ethnicity, and national origin. Description of Director Qualifications, Nominating Process and Stockholder Nominations Members of our Board of Directors should meet certain minimum qualifications including being at least 21 years old and possessing (1) the ability to read and understand corporate financial statements, (2) relevant business experience and professional skills, (3) high moral character and personal and professional integrity, and (4) the willingness to commit sufficient time to attend to his or her duties and responsibilities as a director of a public corporation. In addition, the Board of Directors may consider a variety of other qualities and skills, including (i) expertise in the businesses in which Supernus may engage, (ii) the ability to exercise independent decision-making, (iii) the absence of conflicts of interest, (iv) diversity of experience, and (v) the ability to work effectively with other directors in collectively serving the long-term interests of all stockholders. Nominees must also meet any applicable requirements of SEC regulations, Nasdaq rules, state law and Supernus’ charter and bylaws. The Governance and Nominating Committee of the Board of Directors will annually assess the